Form 4: Agilon Health Executive Reports Stock Transactions

Agilon Health's Chief Markets Officer, Benjamin Shaker, reported transactions involving common stock and restricted stock units.

Summary

• Benjamin Shaker, Chief Markets Officer of agilon health, inc., reported a transaction on April 1, 2026.
• 1,664 shares of common stock were withheld by the issuer to cover tax obligations related to the net settlement of restricted stock units.
• This withholding does not represent a sale of shares.
• Following this transaction and a 1-for-25 reverse stock split effective March 30, 2026, Shaker beneficially owns 53,525 shares of common stock.
• Additionally, 70,000 restricted stock units were acquired on April 1, 2026, with a transaction price of $0.
• These restricted stock units vest in three equal installments annually starting April 1, 2026, contingent upon continued employment.
• Shaker beneficially owns a total of 123,525 shares, including these restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily details routine executive compensation and a corporate action (reverse stock split) rather than significant operational or financial performance changes.

Positives

• Acquisition of 70,000 restricted stock units, indicating continued incentive for management.
• Vesting schedule for restricted stock units aligns with continued employment, promoting retention.

Negatives

• Withholding of 1,664 shares for tax purposes, reducing the immediate number of shares held by the executive.

Risks

• The value of the 70,000 restricted stock units is subject to the future performance of agilon health, inc.'s stock price.
• Continued employment is a condition for the vesting of restricted stock units, implying potential forfeiture if employment ceases.

Future Outlook

The restricted stock units acquired on April 1, 2026, are set to vest in three equal installments on each anniversary of that date, subject to continued employment.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The acquisition of restricted stock units is a common form of executive compensation designed to align management's interests with long-term shareholder value. The reverse stock split is often implemented to increase the per-share trading price, which can be a requirement for listing on certain stock exchanges or to appeal to a broader investor base.

Stakeholder Impact

• Shareholders: The reverse stock split may impact the perceived value and trading liquidity of shares. The acquisition of RSUs by management aligns their interests with long-term company performance.
• Employees: The vesting of RSUs is contingent on continued employment, reinforcing employee retention efforts.
• Management: Benjamin Shaker receives equity incentives tied to continued service and company performance.

Next Steps

• Vesting of restricted stock units on April 1, 2027, April 1, 2028, and April 1, 2029, contingent on continued employment.

Key Dates

Keywords

agilon health, AGL, Form 4, insider trading, stock transaction, restricted stock units, beneficial ownership, executive compensation, reverse stock split